SF
Ferrari, Serge Livio
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Predictive value of BMD for hip and other fractures : a meta-analysis to update FRAX | Osteoporosis international | 2026 | 6 | 0 | |||
| A meta-analysis of smoking and fracture risk to update the FRAX® tool | Osteoporosis international | 2026 | 3 | 0 | |||
| Early transition from short-term romosozumab to antiresorptive therapies : analysis of 26 cases | Archives of osteoporosis | 2025 | 5 | 57 | |||
| Traitements médicamenteux séquentiels de l’ostéoporose | Revue médicale suisse | 2025 | 43 | 1 | |||
| Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists | Archives of osteoporosis | 2025 | 21 | 1 | |||
| Rheumatoid arthritis and subsequent fracture risk : an individual person meta-analysis to update FRAX | Osteoporosis international | 2025 | 58 | 0 | |||
| LUMIADE 3 : Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis | Journal of the Endocrine Society | 2025 | 4 | 21 | |||
| Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis | JBMR plus | 2025 | 8 | 72 | |||
| Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score more than denosumab continuation in postmenopausal women | Journal of bone and mineral research | 2025 | 4 | 0 | |||
| A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis | Osteoporosis international | 2025 | 11 | 10 | |||
| Body mass index and subsequent fracture risk : a meta-analysis to update FRAX | Journal of bone and mineral research | 2025 | 9 | 63 | |||
| Are low-trauma fractures all fragility fractures ? Insights into musculoskeletal and body composition characteristics of community-dwelling post-menopausal women with a recent fracture | Aging Clinical and Experimental Research | 2025 | 28 | 69 | |||
| A Consensus Statement on the management of Vertebral Fractures in CKD stages G4-G5D | Nephrology, dialysis, transplantation | 2025 | 10 | 63 | |||
| Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes | The Journal of clinical endocrinology and metabolism | 2025 | 69 | 245 | |||
| Asia-Pacific consensus for the management of osteoporosis in men | Osteoporosis international | 2025 | 45 | 164 | |||
| Bone microstructure and TBS in diabetes: what have we learned ? A narrative review | Osteoporosis international | 2025 | 5 | 0 | |||
| Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool | Osteoporosis international | 2025 | 14 | 0 | |||
| Ostéoporose : ces malades qu’on ignore malgré des traitements efficaces | Revue médicale suisse | 2025 | 25 | 0 | |||
| Efficacité clinique des traitements de l’ostéoporose | Revue médicale suisse | 2025 | 35 | 0 | |||
| Prise en charge de la fragilité osseuse du patient diabétique | Revue médicale suisse | 2025 | 36 | 0 | |||
| Alternated activation with relaxation of periosteum stimulates bone modeling and remodeling | Scientific reports | 2024 | 53 | 22 | |||
| Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | 2024 | 120 | 145 | |||
| The challenge of hypophosphatasia diagnosis in adults : results from the HPP International Working Group Literature Surveillance | Osteoporosis international | 2024 | 63 | 1 | |||
| Effects of Dalcroze eurhythmics exercise versus multicomponent exercise on physical and cognitive function, and falls in older adults : the EPHYCOS randomized controlled trial | Advanced biology | 2024 | 100 | 246 | |||
| Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extension | Journal of bone and mineral research | 2024 | 70 | 348 | |||
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2024 | 80 | 67 | |||
| Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort study | Journal of bone and mineral research | 2024 | 58 | 0 | |||
| Validation of a fall rate prediction model for community-dwelling older adults : a combined analysis of three cohorts with 1850 participants | BMC geriatrics | 2024 | 39 | 120 | |||
| Maladies osseuses : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 136 | 94 | |||
| Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohorts | Journal of bone and mineral research | 2024 | 181 | 282 | |||
| Hypophosphatasia diagnosis : current state of the art and proposed diagnostic criteria for children and adults | Osteoporosis international | 2024 | 64 | 124 | |||
| 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate | Journal of bone and mineral research | 2024 | 120 | 157 | |||
| Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents : results from the HPP International Working Group | Osteoporosis international | 2024 | 40 | 47 | |||
| A meta-analysis of previous falls and subsequent fracture risk in cohort studies | Osteoporosis international | 2024 | 84 | 0 | |||
| Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 Diabetes | Journal of clinical medicine | 2023 | 76 | 192 | |||
| NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice | RMD open | 2023 | 239 | 87 | |||
| Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ? | Revue médicale suisse | 2023 | 95 | 187 | |||
| High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture | European journal of endocrinology | 2023 | 230 | 235 | |||
| 2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software | Frontiers in bioengineering and biotechnology | 2023 | 114 | 58 | |||
| Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials | BMJ | 2023 | 92 | 20 | |||
| Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma | Radiology case reports | 2023 | 154 | 131 | |||
| Biochemical Markers of Bone Fragility in Patients With Diabetes | The Journal of clinical endocrinology and metabolism | 2023 | 94 | 0 | |||
| A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography | Journal of bone and mineral research | 2023 | 134 | 97 | |||
| The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trial | Obesity | 2023 | 263 | 84 | |||
| Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone | Nature reviews. Rheumatology | 2023 | 69 | 0 | |||
| Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older women | Aging Clinical and Experimental Research | 2023 | 161 | 58 | |||
| Previous fracture and subsequent fracture risk : a meta-analysis to update FRAX | Osteoporosis international | 2023 | 88 | 279 | |||
| Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approach | BMC geriatrics | 2023 | 96 | 161 | |||
| Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism | Nutrients | 2022 | 179 | 173 | |||
| Romosozumab efficacy and safety in European patients enrolled in the FRAME trial | Osteoporosis international | 2022 | 221 | 148 | |||
| Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium Intake | Nutrients | 2022 | 163 | 291 | |||
| Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan | Osteoporosis international | 2022 | 252 | 0 | |||
| Fracture risk following an atypical femoral fracture | Journal of bone and mineral research | 2022 | 270 | 320 | |||
| Regeneration of Craniofacial Bone Induced by Periosteal Pumping | Tissue engineering. Part C Methods | 2022 | 265 | 2 | |||
| Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk | Journal of bone and mineral research | 2022 | 358 | 510 | |||
| Pumping the Periosteum : A Feasibility Study | Annals of plastic surgery | 2022 | 32 | 0 | |||
| Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures | Calcified tissue international | 2022 | 388 | 491 | |||
| Pathophysiology of vascular calcification and bone loss: linked disorders of ageing? | Nutrients | 2021 | 246 | 225 | |||
| Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | 2021 | 422 | 410 | |||
| Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients | Clinical chemistry and laboratory medicine | 2021 | 309 | 240 | |||
| A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With Aging | Journal of Bone and Mineral Research | 2021 | 201 | 0 | |||
| Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women | Osteoporosis international | 2021 | 151 | 0 | |||
| Covid 19 - vitamine D - traitement de l'ostéoporose | Revue médicale suisse | 2021 | 216 | 192 | |||
| Bone fragility in patients affected by congenital diseases non skeletal in origin | Orphanet Journal of Rare Diseases | 2021 | 206 | 312 | |||
| Développement et évaluation des filières de l'ostéoporose en Suisse | Revue médicale suisse | 2021 | 304 | 414 | |||
| European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | 2021 | 252 | 4 | |||
| Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | Advances in therapy | 2021 | 183 | 1,216 | |||
| Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services | Osteoporosis international | 2021 | 274 | 274 | |||
| Ostéoporose - Nouvelle molécule, nouvelles directives | Revue médicale suisse | 2021 | 128 | 78 | |||
| RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone Fragility | Journal of Bone and Mineral Research | 2021 | 280 | 1 | |||
| Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice | Frontiers in Cell and Developmental Biology | 2021 | 220 | 112 | |||
| Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals | JBMR plus | 2021 | 238 | 247 | |||
| Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus? | Calcified tissue international | 2021 | 283 | 0 | |||
| Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional study | Journal of bone and mineral research | 2021 | 198 | 0 | |||
| The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI study | Nutrients | 2021 | 184 | 199 | |||
| Short or long-term osteoporosis therapy with denosumab ? | Journal of clinical endocrinology & metabolism | 2021 | 150 | 146 | |||
| Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing Antibodies | Journal of Bone and Mineral Research | 2021 | 238 | 0 | |||
| Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocol | BMC Geriatrics | 2021 | 262 | 170 | |||
| Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study | Osteoporosis international | 2021 | 123 | 0 | |||
| Romosozumab : un nouveau traitement de l'ostéoporose sévère | Revue médicale suisse | 2021 | 1,178 | 1,111 | |||
| Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal women | The American Journal of Clinical Nutrition | 2020 | 276 | 5 | |||
| A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement | Osteoporosis International | 2020 | 310 | 209 | |||
| 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) | Swiss Medical Weekly | 2020 | 495 | 648 | |||
| Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF | The Journal of clinical endocrinology and metabolism | 2020 | 171 | 355 | |||
| Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk | Osteoporosis International | 2020 | 239 | 0 | |||
| Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study | Journal of Bone and Mineral Research | 2020 | 212 | 545 | |||
| Ostéoporose | Revue médicale suisse | 2020 | 130 | 291 | |||
| Hand grip strength and early mortality after hip fracture | Archives of Osteoporosis | 2020 | 214 | 0 | |||
| Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension | Bone | 2020 | 357 | 2 | |||
| Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed | Bone | 2020 | 304 | 2 | |||
| Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence | Journal of Bone and Mineral Research | 2020 | 274 | 5 | |||
| The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy study | Clinical Interventions in Aging | 2020 | 438 | 235 | |||
| T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial | Journal of Bone and Mineral Research | 2020 | 307 | 139 | |||
| Vitamin K and Osteoporosis | Nutrients | 2020 | 238 | 400 | |||
| Fracture risk following intermission of osteoporosis therapy | Osteoporosis International | 2019 | 335 | 1 | |||
| Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment | Journal of Clinical Endocrinology and Metabolism | 2019 | 348 | 1 | |||
| RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass | Journal of Clinical Investigation | 2019 | 446 | 426 | |||
| Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women | Osteoporosis International | 2019 | 317 | 1 | |||
| Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study | The Lancet Diabetes & Endocrinology | 2019 | 404 | 0 | |||
| Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis | Osteoporosis International | 2019 | 359 | 1 | |||
| Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | Advances in Therapy | 2019 | 297 | 179 | |||
| Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment | Journal of Bone and Mineral Research | 2019 | 437 | 378 | |||
| Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients | Osteoporosis International | 2019 | 337 | 1 | |||
| Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region | Journal of Clinical Densitometry | 2019 | 312 | 320 | |||
| Diabetes and fracture risk | Primer on the metabolic bone diseases and disorders of mineral metabolism | 2019 | 311 | 3 | |||
| Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity study | Clinical Interventions in Aging | 2018 | 573 | 322 | |||
| Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension | Journal of Bone and Mineral Research | 2018 | 458 | 1 | |||
| Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome | Journal of Bone and Mineral Research | 2018 | 435 | 0 | |||
| Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women | Journal of Bone and Mineral Research | 2018 | 622 | 0 | |||
| Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women | Osteoporosis International | 2018 | 465 | 6 | |||
| β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice | American Journal of Physiology. Endocrinology and Metabolism | 2018 | 420 | 4 | |||
| Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure | Osteoporosis International | 2018 | 604 | 1 | |||
| FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab | Journal of Bone and Mineral Research | 2018 | 443 | 0 | |||
| Osteoporosis: Romosozumab to rebuild the foundations of bone strength | Nature Reviews Rheumatology | 2018 | 465 | 0 | |||
| Ostéoporose | Revue médicale suisse | 2018 | 344 | 2 | |||
| Phosphate wasting disorders in adults | Osteoporosis International | 2018 | 429 | 1 | |||
| Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study | Frontiers in Pharmacology | 2018 | 557 | 246 | |||
| Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | 2018 | 465 | 3 | |||
| Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | 2018 | 538 | 3 | |||
| Ostéoporose chez l'insuffisant rénal : quelle évaluation et quel traitement? Place de la biopsie osseuse | Revue médicale suisse | 2018 | 407 | 1 | |||
| The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis | Calcified Tissue International | 2018 | 399 | 0 | |||
| Prevention of fractures in patients with osteoporosis | The Lancet | 2018 | 471 | 1 | |||
| Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallers | European Review of Aging and Physical Activity | 2018 | 469 | 320 | |||
| Ostéoporose | Revue médicale suisse | 2018 | 445 | 149 | |||
| Diagnosis and management of bone fragility in diabetes: an emerging challenge | Osteoporosis International | 2018 | 434 | 279 | |||
| Les métamorphoses du traitement de l'ostéoporose | Revue médicale suisse | 2017 | 392 | 40 | |||
| Evaluation of hip abductor and adductor strength in the elderly: a reliability study | European review on aging and physical activity | 2017 | 510 | 299 | |||
| Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX | Journal of Bone and Mineral Research | 2017 | 528 | 0 | |||
| Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone | Calcified Tissue International | 2017 | 524 | 1 | |||
| Cathepsin K Controls Cortical Bone Formation by Degrading Periostin | Journal of Bone and Mineral Research | 2017 | 479 | 1 | |||
| IOF Compendium of Osteoporosis | 2017 | 1,402 | 427 | ||||
| Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | The American journal of clinical nutrition | 2017 | 690 | 3 | |||
| Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study | BMC musculoskeletal disorders | 2017 | 489 | 259 | |||
| Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates | Osteoporosis International | 2017 | 549 | 2 | |||
| Mechanisms of diabetes mellitus-induced bone fragility | Nature reviews. Endocrinology | 2017 | 563 | 0 | |||
| Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO | Swiss Medical Weekly | 2017 | 513 | 242 | |||
| Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in Males | The Journal of clinical endocrinology and metabolism | 2017 | 556 | 0 | |||
| Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 580 | 1 | |||
| Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitement | Swiss Medical Forum | 2017 | 389 | 1 | |||
| Diabetes and Bone | Calcified tissue international | 2017 | 463 | 1 | |||
| Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting | Osteoporosis International | 2017 | 452 | 0 | |||
| hypophosphatasie de l'adulte | Revue médicale suisse | 2017 | 522 | 6 | |||
| Jusqu'où et jusqu'à quand traiter l'ostéoporose? | Revue médicale suisse | 2017 | 436 | 124 | |||
| Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males? | Journal of Bone and Mineral Research | 2017 | 512 | 0 | |||
| Within and across-sex inheritance of bone microarchitecture | The Journal of clinical endocrinology and metabolism | 2017 | 1,520 | 10 | |||
| Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Therapeutic advances in musculoskeletal disease | 2016 | 538 | 0 | |||
| Le traitement séquentiel présente des avantages | Leading Opinions. Médecine Interne | 2016 | 407 | 1 | |||
| Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses | BoneKEy Reports | 2016 | 440 | 232 | |||
| Traitement de l'ostéoporose : quel médicament et pour qui? | La gazette médicale - info@gériatrie | 2016 | 527 | 1,175 | |||
| Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | Calcified tissue international | 2016 | 589 | 3 | |||
| Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | Journal of bone and mineral research | 2016 | 602 | 7 | |||
| The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | Osteoporosis international | 2016 | 488 | 0 | |||
| Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Archives of osteoporosis | 2016 | 548 | 321 | |||
| Periostin action in bone | Molecular and cellular endocrinology | 2016 | 430 | 0 | |||
| Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | European journal of endocrinology | 2016 | 470 | 1 | |||
| Occupation-dependent loading increases bone strength in men | Osteoporosis international | 2016 | 671 | 3 | |||
| Romosozumab Treatment in Postmenopausal Women with Osteoporosis | The New England journal of medicine | 2016 | 1,070 | 1,636 | |||
| Santé osseuse des retraités genevois | Revue médicale suisse | 2015 | 521 | 2 | |||
| Gene–Diet Interactions on Bone | Nutrition and Bone Health | 2015 | 656 | 1 | |||
| Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years | Osteoporosis international | 2015 | 536 | 0 | |||
| Periostin expression contributes to cortical bone loss during unloading | Bone | 2015 | 556 | 1 | |||
| Calcinose cutanée associée aux connectivites | Revue médicale suisse | 2015 | 1,146 | 3 | |||
| Taxonomy of rare genetic metabolic bone disorders | Osteoporosis international | 2015 | 566 | 0 | |||
| Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure | The Journal of clinical endocrinology and metabolism | 2015 | 614 | 0 | |||
| Sauvons l'ostéoporose | Revue médicale suisse | 2015 | 467 | 0 | |||
| Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations | Osteoporosis international | 2015 | 604 | 1 | |||
| Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial | The Lancet. Diabetes & endocrinology | 2015 | 576 | 0 | |||
| Osteocytic targets in the treatment of osteoporosis | Osteoporosis international | 2014 | 484 | 0 | |||
| The role of teriparatide in sequential and combination therapy of osteoporosis | Schweizerische medizinische Wochenschrift | 2014 | 696 | 1 | |||
| Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women | BMC musculoskeletal disorders | 2014 | 745 | 183 | |||
| Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene | Current medical research and opinion | 2014 | 527 | 0 | |||
| Goal-directed treatment of osteoporosis in Europe | Osteoporosis international | 2014 | 540 | 1 | |||
| Future directions for new medical entities in osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | 2014 | 486 | 0 | |||
| Fractures ostéoporotiques: pas seulement chez les femmes | Revue médicale suisse | 2014 | 499 | 0 | |||
| Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice | Journal of bone and mineral research | 2014 | 621 | 0 | |||
| Tracking of Environmental Determinants of Bone Structure and Strength Development in Healthy Boys: An Eight-Year Follow Up Study on the Positive Interaction Between Physical Activity and Protein Intake From Prepuberty to Mid-Late Adolescence | Journal of bone and mineral research | 2014 | 669 | 1 | |||
| Impaired Musculoskeletal Response to Age and Exercise in PPARβ −/− Diabetic Mice | Endocrinology | 2014 | 539 | 453 | |||
| Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius | Bone | 2013 | 567 | 0 | |||
| Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice | PloS one | 2013 | 674 | 389 | |||
| Effect of a multifactorial fall-and-fracture risk assessment and management program on gait and balance performances and disability in hospitalized older adults: a controlled study | Osteoporosis international | 2013 | 634 | 554 | |||
| Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | 2013 | 560 | 0 | |||
| Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women | The Journal of clinical endocrinology and metabolism | 2013 | 728 | 0 | |||
| Eliminating the need for fasting with oral administration of bisphosphonates | Therapeutics and clinical risk management | 2013 | 633 | 463 | |||
| Diabète et ostéoporose | Revue médicale suisse | 2013 | 562 | 0 | |||
| Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult Mice | PloS one | 2013 | 616 | 335 | |||
| Peak bone mass and its regulation | Pediatric Bone, Second Edition | 2012 | 533 | 2 | |||
| A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis | The Journal of clinical investigation | 2012 | 790 | 0 | |||
| Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective | Journal of bone and mineral research | 2012 | 590 | 0 | |||
| Osteoporosis in young adults: pathophysiology, diagnosis, and management | Osteoporosis international | 2012 | 712 | 1,481 | |||
| Antidepressant medications and osteoporosis | Bone | 2012 | 601 | 0 | |||
| Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation | Journal of bone and mineral research | 2012 | 559 | 0 | |||
| Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? | Osteoporosis international | 2012 | 626 | 0 | |||
| Physical activity increases bone mineral density in children with type 1 diabetes | Medicine and science in sports and exercise | 2012 | 675 | 1 | |||
| Behandlung der Osteoporose mit Denosumab | Therapeutische Umschau | 2012 | 564 | 0 | |||
| Fractures in Healthy Females Followed from Childhood to Early Adulthood Are Associated with Later Menarcheal Age and with Impaired Bone Microstructure at Peak Bone Mass | The Journal of clinical endocrinology and metabolism | 2012 | 642 | 0 | |||
| Improvement of bone strength with teriparatide: hip as well as spine? | IBMS boneKEy | 2012 | 426 | 0 | |||
| Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin | Proceedings of the National Academy of Sciences of the United States of America | 2012 | 688 | 0 | |||
| Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity | International journal of obesity | 2012 | 769 | 5 | |||
| Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trial | Archives of internal medicine | 2011 | 731 | 2 | |||
| Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | 2011 | 702 | 966 | |||
| Fractures during childhood and adolescence in healthy boys: relation with bone mass, microstructure, and strength | The Journal of clinical endocrinology and metabolism | 2011 | 679 | 414 | |||
| Prévention des chutes par une méthode d'exercice en musique (rythmique Jaques-Dalcroze) | Revue médicale suisse | 2011 | 703 | 2 | |||
| Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study | Journal of bone and mineral metabolism | 2011 | 578 | 248 | |||
| Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels | European journal of endocrinology | 2011 | 605 | 491 | |||
| Bisphosphonates in periodontitis: Friend or foe? | IBMS boneKEy | 2011 | 729 | 0 | |||
| Denosumab and bisphosphonates: Different mechanisms of action and effects | Bone | 2011 | 694 | 0 | |||
| Protéines et croissance osseuse | Archives de pédiatrie | 2011 | 571 | 1 | |||
| Pubertal timing and body mass index gain from birth to maturity in relation with femoral neck BMD and distal tibia microstructure in healthy female subjects | Osteoporosis international | 2011 | 675 | 317 | |||
| Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice | The Journal of nutritional biochemistry | 2011 | 571 | 1 | |||
| Traitement de l'ostéoporose par les agents biologiques | Je veux en savoir plus | 2011 | 479 | 0 | |||
| Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans | Journal of bone and mineral research | 2011 | 586 | 0 | |||
| Decreased bone turnover in children and adolescents with well controlled type 1 diabetes | Journal of pediatric endocrinology & metabolism | 2010 | 615 | 2 | |||
| Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture | Osteoporosis international | 2010 | 619 | 400 | |||
| Ostéoporose: du diagnostic ostéodensitométrique à l'évaluation du risque absolu de fracture | Journal für Mineralstoffwechsel | 2010 | 609 | 3 | |||
| Pathophysiology of postmenopausal osteoporosis | Atlas of Postmenopausal Osteoporosis. Third Edition | 2010 | 541 | 0 | |||
| Exercise and the skeleton: How it works and what it really does | IBMS boneKEy | 2010 | 985 | 1,727 | |||
| Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL | The Journal of biological chemistry | 2010 | 783 | 0 | |||
| Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice | Calcified tissue international | 2010 | 658 | 0 | |||
| Age de la ménarche et risque d'ostéoporose au cours de la vie adulte | Mises au point cliniques d'endocrinologie, nutrition et métabolisme | 2010 | 525 | 2 | |||
| An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits | PLOS genetics | 2010 | 1,077 | 374 | |||
| Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | 2010 | 541 | 0 | |||
| β-Arrestin-biased parathyroid hormone ligands: A new approach to the development of agents that stimulate bone formation | Science translational medicine | 2009 | 554 | 0 | |||
| The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity | The Journal of biological chemistry | 2009 | 632 | 1 | |||
| Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight | PloS one | 2009 | 703 | 484 | |||
| Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts | Bone | 2009 | 660 | 669 | |||
| Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases | International journal of clinical practice | 2009 | 576 | 0 | |||
| Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy | Endocrinology | 2009 | 626 | 0 | |||
| The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarche | The Journal of clinical endocrinology and metabolism | 2009 | 594 | 1 | |||
| Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged women | Journal of bone and mineral research | 2009 | 620 | 0 | |||
| Continuous broad protection against osteoporotic fractures with strontium ranelate | Rheumatology | 2009 | 625 | 1 | |||
| Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice | Journal of bone and mineral research | 2009 | 584 | 0 | |||
| Differentiation of osteoporotic and neoplastic vertebral fractures by chemical shift {in-phase and out-of phase} MR imaging | European journal of radiology | 2009 | 605 | 0 | |||
| Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis | Journal of Musculoskeletal and Neuronal Interactions | 2008 | 562 | 0 | |||
| PPARG by dietary fat interaction influences bone mass in mice and humans | Journal of bone and mineral research | 2008 | 590 | 0 | |||
| High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys | Journal of bone and mineral research | 2008 | 607 | 0 | |||
| Secondary prevention of osteoporotic fractures: why not apply the evidence? | Schweizerische medizinische Wochenschrift | 2008 | 533 | 0 | |||
| Influence of age at menarche on forearm bone microstructure in healthy young women | The Journal of clinical endocrinology and metabolism | 2008 | 705 | 0 | |||
| Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight | Journal of bone and mineral research | 2008 | 593 | 0 | |||
| Genomewide Association Studies in Osteoporosis: Have We Reached the Bottom of the Ocean or the Tip of the Iceberg? | IBMS boneKEy | 2008 | 546 | 0 | |||
| Leptin and the sympathetic connection of fat to bone | Osteoporosis international | 2008 | 596 | 0 | |||
| Contribution of gender-specific genetic factors to osteoporosis risk | Annals of human genetics | 2008 | 531 | 0 | |||
| Site specificity of fracture prediction in children | Journal of bone and mineral research | 2008 | 494 | 0 | |||
| Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis | JAMA | 2008 | 606 | 0 | |||
| Human genetics of osteoporosis | Baillière's best practice & research. Clinical endocrinology & metabolism | 2008 | 643 | 2 | |||
| Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass | Current opinion in lipidology | 2005 | 578 | 0 | |||
| LRP5 gene polymorphisms and idiopathic osteoporosis in men | Bone | 2005 | 593 | 0 | |||
| beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 564 | 0 | |||
| Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites | American journal of human genetics | 2004 | 579 | 0 | |||
| Parathyroid hormone-related protein increases cAMP production in mammary epithelial cells | The American journal of physiology | 1993 | 560 | 0 |
